University of Texas Medical Branch
Hematology and Oncology fellowship · Galveston, TX · Program website
This program's roster hasn't been collected yet, so there's no list of its own faculty and papers. Below is The University of Texas Medical Branch at Galveston's research in hematology and oncology, which the program shares with other departments and affiliated hospitals.
About The University of Texas Medical Branch at Galvestoninstitution-wide hematology and oncology research
Hematology and Oncology publications from The University of Texas Medical Branch at Galveston and affiliated institutions, since 2022. Updated 2026-11-06; refreshed daily.
59
works per year
50th of 74 hematology and oncology fellowship programs
+17.6%
2-year growth
26th of 74 hematology and oncology fellowship programs
14.7%
in top 10% of field (works before 2025)
61st of 72 hematology and oncology fellowship programs
29.5%
cited above world average
64th of 72 hematology and oncology fellowship programs
Works per year · * 2026 so far
Oncology · 249Hematology · 62
Hematology and Oncology research topics at The University of Texas Medical Branch at Galveston
Papers in the window; each links to the list on OpenAlex.
- Cancer Immunotherapy and Biomarkers 47
- Cutaneous Melanoma Detection and Management 34
- Cancer survivorship and care 26
- Global Cancer Incidence and Screening 20
- Pancreatic and Hepatic Oncology Research 15
- Multiple Myeloma Research and Treatments 12
- COVID-19 and healthcare impacts 12
- Viral-associated cancers and disorders 11
Most cited at The University of Texas Medical Branch at Galveston since 2024
All hematology and oncology papers there on OpenAlex
- The global, regional, and national burden of cancer, 1990–2023, with forecasts to 2050: a systematic analysis for the Global Burden of Disease Study 2023Lisa M Force et al. · The Lancet · 2025 · PubMed · cited 498
- Global, regional, and national burden of breast cancer among females, 1990–2023, with forecasts to 2050: a systematic analysis for the Global Burden of Disease Study 2023Kayleigh Pavitra Bhangdia et al. · The Lancet Oncology · 2026 · PubMed · cited 174
- MDM2 Inhibitors for Cancer Therapy: The Past, Present, and FutureWei Wang et al. · Pharmacological Reviews · 2024 · PubMed · cited 148
- Platelet TransfusionRyan A. Metcalf et al. · JAMA · 2025 · PubMed · cited 140
- Global, regional and national burden of dietary iron deficiency from 1990 to 2021: a Global Burden of Disease studySooji Lee et al. · Nature Medicine · 2025 · PubMed · cited 57
- The future of cancer treatment: combining radiotherapy with immunotherapyGunjan Dagar et al. · Frontiers in Molecular Biosciences · 2024 · PubMed · cited 35
- Single-cell profiling of bone metastasis ecosystems from multiple cancer types reveals convergent and divergent mechanisms of bone colonizationFengshuo Liu et al. · Cell Genomics · 2025 · PubMed · cited 30
- Multi-parametric thrombus profiling microfluidics detects intensified biomechanical thrombogenesis associated with hypertension and agingMisbahud Din et al. · Nature Communications · 2024 · PubMed · cited 26
- Insights into the relevance of targeting fibroblasts to control cancerViktoria Boeker et al. · Cell Reports Medicine · 2025 · PubMed · cited 25
- Clinical Utility of a Digital Dermoscopy Image-Based Artificial Intelligence Device in the Diagnosis and Management of Skin Cancer by DermatologistsAlexander Michael Witkowski et al. · Cancers · 2024 · PubMed · cited 22